Search Results 2971-2980 of 16411 for Chiari malformation
Phase 1 Study to Evaluate MEDI4736 in Subjects With Myelodysplastic Syndrome. Scottsdale/Phoenix, Ariz., Rochester, Minn. This is a multicenter, open-label ...
... syndrome, and all-cause mortality 6 months after the event, and (2) improves stroke outcomes at 3 months in patients who experienced an ischemic stroke.
Participation eligibility · Current clinically significant cardiovascular disease, ECG abnormalities, risk factors for Torsades de Pointes, or are taking drugs ...
Cancer. · Endocrine and metabolic conditions. · Gastrointestinal diseases. · Genomics, especially genetic epidemiology. · Heart, lung and blood disorders. · Kidney ...
He diagnosed her with Sjogren's Syndrome, an autoimmune disorder. He put her on medication, but it didn't resolve any of her symptoms. With worsening ...
One of these biospecimen collections is the Mayo Clinic Biobank, a collection of samples, including blood and blood derivatives, and health information donated ...
During her recovery, Vera underwent an MRI, which revealed brain abnormalities consistent with mitochondrial disease. She also had blood clots from being so ...
Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with genetic changes or abnormalities (mutations) may benefit more ...
In this study, participants with relapsed or refractory primary mediastinal large B-cell lymphoma (rrPMBCL) or relapsed or refractory Richter Syndrome (rrRS) ...
... Syndrome (MDS), or Chronic Myelomonocytic Leukemia-2 (CMML-2). Jacksonville, Fla. The purpose of this study is to evaluate the safety and effectiveness of ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.